Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
In response to fruits question regarding other viruses. Early research I did on Synairgen revealed that this had previously been tested on SARS and MERS and was giving good results but the virus didn’t stay around long enough for full trials to be completed so couldn’t give conclusive results. For me this was enough to prompt me to top up. I think I’ve also read that this could be trialled against the flu once Covid is under control, if it is approved for Covid I’m sure approval for alternative use would come about much quicker.
Feel like that was a real possibility if RM could just have got data a few months earlier. Now i think we still see a very pleasant rise to 5-10, but those huge gains seem less likely.
and some more pointless bile.
The clouds were many colours today, the tea leaves say this suggests drifting sp but wise men invested elsewhere have at least tried to warn you.
Post of the day for me Rorkes, brilliant
The chances of a chimp giving birth to an orangutang are zero. I know this cause I watched planet of the apes. The one with Charleston Heston and that great ending.
Oh hang on.......
Absolutely right Kevin1977.
One step at a time, and re-evaluate the future possibilities after each step.
The question that you succinctly responded to was asked by a clueless troll, who occasionally graces the board with his presence, and asks silly questions. I doubt whether he is a Synairgen investor.
Regards, and good wishes.
SYGGF up just over 18% atm
Asking if £20 is possible at this point is pointless.
How can anyone accurately answer that, would be pure speculation.
Let’s get to £2 first.
Then let’s get last patient dosed, then P3 readout, EUA, then maybe ask the same question.
The market is massive and beyond anyone`s real expectation as this is not just COVID related - Add Flu and COPD for starters and its mind boggling, it really is and makes a take over almost a certainty
Good day for all concerned.
Gold
It would be a pretty stupid thing for the virus to do as that is its advantage at the moment. Viruses tend to work in the opposite way and get better at using a successful mechanism to invade a host.
Thanks Matlm, that is precisely what I should have said rather than waffle as I did :-). I understand the mechanism, my question really, as you so eloquently put it, is whether "future variants will or can move away from the mechanism of IFN suppression"? Could that happen? I know it's unlikely, but in terms of risk, could it?
I will read that article, thanks for the link.
Fruits - The drug doesn't act against the virus. It is an immunomodulator (ie. helps the host immune system), hence the agnostic label it has been given. The way covid works is by suppressing the INF immune response. So for covid, unless future variants move away from the mechanism of IFN suppression in its host, which is a significant advantage to the virus to its survival, then SNG001 should work against all covid variants.
There is a good paper out today in the Lancet overviewing Interferon's in lung infections - Off balance: Interferons in COVID-19 lung infections
https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(21)00435-7/fulltext
Love this. Typical AIM chat. A few weeks ago this was scrapping 130 odds and was pants. Today its what colour is my ferrari.
er NDn, Do your research properly please or is your head full of Avacta? You lot are hilarious and so obvious. Go and find a bendy tree to shake, you and your pincer of supposed subtlety is not being invested in here.
20 by April 2022
With giant haystacks :)
Blimey, the last time I saw tag teaming like this it was on a Saturday afternoon as a kid watching "Big Daddy"
Thanks Andybe4, nice writeup.
Looks like Jwd is just a troll.
Question: could we come up against a variant that the drug doesn't work against (if so liklihood low as it's already proven on 1 or 2 so far)?
Lets start with £2 before we talk about £20 and £50
That’s too much
It depends on things out of the company’s control.
Let’s just hope that SNG001 passes Phase 3 SPRINTER trial. This looks a lot more probable now that we have just been put through to Phase 3 Activ 2.
As long as it works in SPRINTER, it should get FDA approval, in which case there are a multitude of factors that will affect the SP:
1. Big pharma takeover? Highly possible.
2. Severity of Delta, or possible new variants.
3. Vaccine escape variant, potentially renders the current vaccines useless (this is the big one, will shake the markets again and cause the mother of all crashes, but Synairgen will be an eagle and soar).
4. Potential development of drug in other trials. I think a US government asthma trial was mentioned. If SNG001 also participates, it shows the multi purposes of the drug. In which case a takeover looks inevitable.
Despite at times being extremely frustrated, I have maintained my bullish position that ultimately the SP will go to £15 or even as high as £20.
Probably more like £50 per share.
Who knows? Pointless to speculate
As you own zero shares neither is likely